These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8189583)

  • 1. T helper cell alveolitis after bacillus Calmette-Guerin immunotherapy for superficial bladder tumor.
    Reinert KU; Sybrecht GW
    J Urol; 1994 Jun; 151(6):1634-7. PubMed ID: 8189583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids.
    Molina JM; Rabian C; D'Agay MF; Modai J
    J Urol; 1992 Mar; 147(3):695-7. PubMed ID: 1538462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miliary tuberculosis after intravesical Bacillus Calmette-Guerin immunotherapy.
    Şimşek A; Güler M; Günay S; Çapan N
    Tuberk Toraks; 2013; 61(3):252-4. PubMed ID: 24298968
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycobacterial sepsis following intravesical instillation of bacillus Calmette-Guérin.
    Garyfallou GT
    Acad Emerg Med; 1996 Feb; 3(2):157-60. PubMed ID: 8808378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulomatous chest disease following intravesical bacillus Calmette-Guerin immunotherapy.
    Chang H; Klein JS; Norotsky M; Cooper K
    J Thorac Imaging; 2004 Jan; 19(1):60-2. PubMed ID: 14712136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miliary lung disease after intravesical bacillus Calmette-Guérin immunotherapy.
    Jasmer RM; McCowin MJ; Webb WR
    Radiology; 1996 Oct; 201(1):43-4. PubMed ID: 8816518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic hypersensitivity reaction to intravesical BCG.
    Lyons D; Miller I; Jeffers A
    Scott Med J; 1994 Apr; 39(2):49-50. PubMed ID: 8720760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary granulomata. A complication of intravesical administration of bacillus Calmette-Guerin for superficial bladder carcinoma.
    Smith RL; Alexander RF; Aranda CP
    Cancer; 1993 Mar; 71(5):1846-7. PubMed ID: 8448747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated pulmonary granulomas after intravesical bacillus Calmette-Guérin immunotherapy.
    De Diego A; Rogado MC; Prieto M; Nauffal D; Perpiñá M
    Respiration; 1997; 64(4):304-6. PubMed ID: 9257368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin.
    Deresiewicz RL; Stone RM; Aster JC
    J Urol; 1990 Dec; 144(6):1331-3; discussion 1333-4. PubMed ID: 2231918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity pneumonitis following intravesical bacille Calmette-Guérin immunotherapy for superficial bladder cancer.
    Um SJ; Lee SK; Yang DK
    J Investig Allergol Clin Immunol; 2009; 19(3):230-2. PubMed ID: 19610267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].
    Kudo T; Iwasa N; Maeda S; Mitarai S
    Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity pneumonitis as a complication of intravesical BCG therapy for bladder cancer.
    Carrasco Hernández L; Castaño Núñez ÁL; Rodríguez Portal JA
    Arch Bronconeumol; 2016 Aug; 52(8):445-6. PubMed ID: 26920491
    [No Abstract]   [Full Text] [Related]  

  • 14. New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy.
    Dudelzak J; Curtis AR; Sheehan DJ; Lesher JL
    J Drugs Dermatol; 2008 Jul; 7(7):684. PubMed ID: 18664162
    [No Abstract]   [Full Text] [Related]  

  • 15. Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication.
    Calleris G; Marra G; Corcione S; Oderda M; Cardellino C; Audagnotto S; Frea B; De Rosa FG; Gontero P
    Infez Med; 2017 Dec; 25(4):366-370. PubMed ID: 29286018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing aspects of bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.
    LeBouton J
    Urol Nurs; 1990 Dec; 10(4):9-14. PubMed ID: 2274796
    [No Abstract]   [Full Text] [Related]  

  • 17. Arthritis after Calmette-Guerin bacillus immunotherapy for bladder cancer.
    Goupille P; Soutif D; Valat JP
    J Rheumatol; 1992 Nov; 19(11):1825-6. PubMed ID: 1491413
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis complications after BCG treatment for urinary bladder cancer.
    Naudžiūnas A; Juškaitė R; Žiaugrytė I; Unikauskas A; Varanauskienė E; Mašanauskienė E
    Medicina (Kaunas); 2012; 48(11):563-5. PubMed ID: 23455890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin.
    Linn R; Klimberg IW; Wajsman Z
    J Urol; 1989 May; 141(5):1197-8. PubMed ID: 2709508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer.
    Iantorno R; Nicolai M; Storto ML; Ciccotosto C; Cipollone G; Mastroprimiano G; Tenaglia RL
    J Urol; 1998 May; 159(5):1639-40. PubMed ID: 9554372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.